Ipca Laboratories (NSE:IPCALAB) Net Interest Margin (Bank Only) %


NSE:IPCALAB Ipca Laboratories Ltd NSE:IPCALAB
90 GF Score
Price ₹1,778.90
GF Value ₹1,598.63
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is Ipca Laboratories Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

NSE:IPCALAB
90GF Score
Ipca Laboratories Ltd NSE:IPCALAB
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Ipca Laboratories (NSE:IPCALAB) Overvalued in 2026?

Based on GuruFocus' analysis, Ipca Laboratories stock appears to be overvalued. The current stock price of ₹1,778.90 is trading 11.3% above its estimated GF Value™ of ₹1,598.63. GuruFocus considers Ipca Laboratories to be Modestly Overvalued.

Key valuation signals for NSE:IPCALAB:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: ₹1,598.63 vs. price of ₹1,778.90 (11.3% above fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the NSE:IPCALAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ipca Laboratories Business Description

Other Exchanges 524494:India
Address No. 48, 123 AB, 125 & 126 Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
90GF Score

Get the complete analysis for NSE:IPCALAB

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,778.90
Price
₹1,598.63
GF Value